23andMe Holding Q4 EPS $(0.14) Beats $(0.16) Estimate, Sales $92.38M Beat $88.40M Estimate
Portfolio Pulse from Benzinga Newsdesk
23andMe Holding reported Q4 losses of $(0.14) per share, beating the $(0.16) estimate, and sales of $92.38M, surpassing the $88.40M estimate. However, sales decreased by 8.14% compared to the same period last year.
May 25, 2023 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
23andMe's Q4 earnings beat estimates with a 12.5% increase in EPS and 4.5% higher sales, but sales are down 8.14% YoY.
23andMe's better-than-expected Q4 earnings, with a 12.5% increase in EPS and 4.5% higher sales, may positively impact the stock price in the short term. However, the 8.14% YoY decrease in sales could be a concern for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100